Poster – Automated Segmentation of MS Brain Lesions

Cortechs.ai was pleased to have this UC San Diego School of Medicine poster presented at ACTRIMS Forum 2018

Automated quantitative measures from MRI, such as lesion volume and distribution, have significant value for clinicians evaluating disease progression. Clinical standards for lesion evaluation include visual inspection of MRI images, or expert manual segmentation of lesions. These subjective measurements lack standardization and reproducibility in clinical settings

Cortechs.ai’ LesionQuant module is a fully-automated lesion segmentation tool for clinical use designed to provide accurate and reproducible lesion segmentations. This study demonstrates that automated segmentation of MS lesion volumes and counts by LesionQuant provides reproducible results that correlate well with expert manual counts and analysis.

For more information about LesionQuant or this poster, contact us. Click image below to view in pdf.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions

Insights

02/02/2025

NeuroQuant® Brain Tumor: Revolutionizing Neuro-Oncology with AI-Driven Precision

Dr. Suzie Bash and Dr. Jeff Rudie dive deep into the advanced functionalities and clinical benefits of the tool that is revolutionizing neuro-oncology

01/28/2025

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Hear from CEO Kyle Frye on the SCALE Community Podcast about how Cortechs.ai is transforming healthcare with cutting-edge AI-powered medical imaging solutions.

01/09/2025

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

This investment propels our mission to revolutionize medical imaging in neuroimaging and oncology, enhancing diagnostic confidence and patient outcomes.
Scroll to Top